Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

Description

A multi-center, prospective active surveillance registry trial assessing the performance of a non-invasive blood test for indolent prostate cancer disease management.

Conditions

Prostate Cancer Aggressiveness

Talk to us

Study Overview

On this page

Study Details

Study overview

A multi-center, prospective active surveillance registry trial assessing the performance of a non-invasive blood test for indolent prostate cancer disease management.

A Multi-center, Prospective Active Surveillance Registry Trial Assessing the Performance of a Non-invasive Immunogenomic Blood Test for Indolent Prostate Cancer Disease Management.

Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

Condition
Prostate Cancer Aggressiveness
Intervention / Treatment

-

Contacts and Locations

Royal Oak

Comprehensive Urology, Royal Oak, Michigan, United States, 48197

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Men with symptoms or rising PSA who have not been proven to have cancer by tissue biopsy i.e. men with only negative prostate biopsies.
  • * Patients with a history of a different cancer (except basal cell carcinoma)

Ages Eligible for Study

40 Years to 80 Years

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Immunis.AI,

Study Record Dates

2029-09-30